Precision medicine study on cardiovascular disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200061515

Enrollment

Unknown

Registered

2022-06-27

Start date

2021-03-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy, cardiac channelopathy, monogenic hypertension, inherited large vessel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cases or suspected cases with monogenic cardiovascular diseases, including various cardiomyopathies, cardiac channelopathy, monogenic hypertension, and inherited large vessel diseases, and their familial members; 2. For proband, the age is >=14; 3. Baseline clinical data are completely collected; 4. Genetic testing has been performed at least in proband before enrollment; 5. Informed consent is provided.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Cardiovascular death;	—

Secondary

Measure	Time frame
Sudden cardiac death;Heart failure related death or heart transplantation;All-cause mortality;New-onset heart failure;New-onset stroke;New-onset atrial fibrilllation;Major adverse cardiac and cerebrovascular events, MACCE;	—

Countries

China

Contacts

Public ContactFanfang Zeng

Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences

precise_consulting@163.com+86 13923752279

Outcome results